Clinical Trial Detail

NCT ID NCT03055286
Title Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors JW Pharmaceutical
Indications

acute myeloid leukemia

Therapies

CWP232291 + Cytarabine

Age Groups: adult senior

No variant requirements are available.